Low total body irradiation (TBI) augments the synergistic anti-tumor effects of anti-CD40 and IL2 immunotherapy

被引：0
|
作者：
Sun, K
Welniak, LA
Wiltrout, R
Blazar, BR
Murphy, WJ
机构：
[1] Univ Nevada, Dept Microbiol & Immunol, Reno, NV 89557 USA
[2] Nevada Canc Inst, Div Basic Res, Las Vegas, NV USA
[3] NCI, Expt Immunol Lab, Frederick, MD 21701 USA
[4] Univ Minnesota, Ctr Canc, Div Bone Marrow Transplantat, Minneapolis, MN USA
来源：
JOURNAL OF IMMUNOTHERAPY | 2004年 / 27卷 / 06期
关键词：
D O I：
10.1097/00002371-200411000-00070
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S19 / S19
页数：1
相关论文
共 50 条
  • [1] The immunotoxicity, but not anti-tumor efficacy, of anti-CD40 and anti-CD137 immunotherapies is dependent on the gut microbiota
    Blake, Stephen J.
    James, Jane
    Ryan, Feargal J.
    Caparros-Martin, Jose
    Eden, Georgina L.
    Tee, Yee C.
    Salamon, John R.
    Benson, Saoirse C.
    Tumes, Damon J.
    Sribnaia, Anastasia
    Stevens, Natalie E.
    Finnie, John W.
    Kobayashi, Hiroki
    White, Deborah L.
    Wesselingh, Steve L.
    O'Gara, Fergal
    Lynn, Miriam A.
    Lynn, David J.
    CELL REPORTS MEDICINE, 2021, 2 (12)
  • [2] A humanized anti-cd40 antibody with anti-tumor pharmacological activity and cynomolgus monkey safety
    Li, Zhenyu
    Zhao, Lili
    Zhang, Guimin
    Li, Bin
    Liu, Zhong
    Li, Guangyan
    Zhu, Zhongsong
    CANCER RESEARCH, 2023, 83 (07)
  • [3] Anti-cryptococcal effect of anti-CD40 and IL-2 immunotherapy in a murine cerebral cryptococcosis model
    Zhou, Qing
    Kozel, Thomas R.
    Murphy, William J.
    JOURNAL OF IMMUNOLOGY, 2006, 176 : S123 - S123
  • [4] Successful immunotherapy with IL-2/anti-CD40 induces the chemokine-mediated mitigation of an immunosuppressive tumor microenvironment
    Weiss, Jonathan M.
    Back, Timothy C.
    Scarzello, Anthony J.
    Subleski, Jeff J.
    Hall, Veronica L.
    Stauffer, Jimmy K.
    Chen, Xin
    Micic, Dejan
    Alderson, Kory
    Murphy, William J.
    Wiltrout, Robert H.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (46) : 19455 - 19460
  • [5] Dose escalation of total body irradiation (TBI) in recipients of CD6 depleted allogeneic bone marrow: Toxicity and anti-tumor effects.
    Soiffer, RJ
    Mauch, P
    Neuberg, D
    Alyea, E
    Fisher, D
    Schlossman, R
    Gribben, J
    Vance, E
    Freedman, A
    Anderson, K
    Kuhlman, C
    Marcus, K
    Nadler, L
    Ritz, J
    BLOOD, 1997, 90 (10) : 1011 - 1011
  • [6] Uncovering the mechanism of synergistic anti-tumor effects in FAP-CD40+PD1-IL2v combination therapy
    Nguyen, Thuy Trinh
    Kunz, Leo
    de Matos, Ines Grazina
    Trumpfheller, Christine
    Umana, Pablo
    CANCER IMMUNOLOGY RESEARCH, 2025, 13 (02)
  • [7] Combination of CTLA-4 blockade with anti-CD40/IL-2 immunotherapy augments the CD8+T cell response in resting and tumor-bearing mice
    Sckisel, Gail
    Nzigira, Ngabo
    Hurwitz, Andrew
    Blazar, Bruce
    Murphy, William
    JOURNAL OF IMMUNOLOGY, 2010, 184
  • [8] Dendritic cell activation by combined exposure to anti-CD40 plus interleukin (IL)-12 and IL-18 efficiently stimulates anti-tumor immunity
    Balkow, Sandra
    Loser, Karin
    Krummen, Mathias
    Higuchi, Tetsuya
    Rothoeft, Tobias
    Apelt, Jenny
    Tuettenberg, Andrea
    Weishaupt, Carsten
    Beissert, Stefan
    Grabbe, Stephan
    EXPERIMENTAL DERMATOLOGY, 2009, 18 (01) : 78 - 87
  • [9] Vascular targeting of anti-CD40 antibodies and IL-2 into autochthonous tumors enhances immunotherapy in mice
    Hamzah, Juliana
    Nelson, Delia
    Moldenhauer, Gerd
    Arnold, Bernd
    Haemmerling, Guenter J.
    Ganss, Ruth
    JOURNAL OF CLINICAL INVESTIGATION, 2008, 118 (05): : 1691 - 1699
  • [10] The efficacy of tumor debulking surgery is improved by adjuvant immunotherapy using imiquimod and anti-CD40
    Andrea Khong
    Amanda L Cleaver
    Muhammad Fahmi Alatas
    Ben C Wylie
    Theresa Connor
    Scott A Fisher
    Steve Broomfield
    Willem J Lesterhuis
    Andrew J Currie
    Richard A Lake
    Bruce W Robinson
    BMC Cancer, 14
12345